Does DULOXETINE Cause Salivary hypersecretion? 46 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Salivary hypersecretion have been filed in association with DULOXETINE (Duloxetine Hydrochloride). This represents 0.1% of all adverse event reports for DULOXETINE.
46
Reports of Salivary hypersecretion with DULOXETINE
0.1%
of all DULOXETINE reports
1
Deaths
19
Hospitalizations
How Dangerous Is Salivary hypersecretion From DULOXETINE?
Of the 46 reports, 1 (2.2%) resulted in death, 19 (41.3%) required hospitalization, and 4 (8.7%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DULOXETINE. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does DULOXETINE Cause?
Nausea (7,355)
Dizziness (6,983)
Drug withdrawal syndrome (6,503)
Headache (5,541)
Fatigue (5,309)
Insomnia (5,270)
Anxiety (4,973)
Paraesthesia (4,854)
Drug ineffective (4,829)
Hyperhidrosis (4,101)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which DULOXETINE Alternatives Have Lower Salivary hypersecretion Risk?
DULOXETINE vs DUPILUMAB
DULOXETINE vs DURAGESIC
DULOXETINE vs DUROGESIC
DULOXETINE vs DUROTEP MT
DULOXETINE vs DURVALUMAB